Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions
1Hematology/Oncology Section, Primary Care Service Line, Minneapolis VA Health Care System, Minneapolis, MN, USA; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Abstract:
Cyclin-dependent kinases (CDKs) play an integral part in cellular activities. To date, most of the activities have been evaluated in the cell cycle and transcription. Several diseases are affected by abnormalities in CDKs, related-pathways, or proteins that regulate CDK activity. CDKs are primarily dependent on activation by binding other proteins, namely Cyclins. In addition, phosphorylation of key CDK residues also plays a major part in CDK activity. To date, the most successful drugs have been developed against CDK4 and CDK6 and are FDA approved for use in advanced breast cancer. However, this is likely only a small fraction of the potential for targeting CDKs as a strategy against cancer and other diseases. Based on the extensive protein-protein interactions made by CDKs with other proteins (Cyclins and others), there are numerous possibilities for targeting strategies against protein-protein interactions. Here we describe the predominant roles of CDKs in the cell, key interacting proteins, significant 3-dimensional structural characteristics, and summarize the work-to-date in inhibition of CDKs.
Insights
Cyclin-dependent kinases (CDKs) are crucial for cell function and are implicated in various diseases. Targeting CDKs, particularly CDK4/6 for breast cancer, shows therapeutic promise for other conditions.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cyclin-dependent kinases (CDKs) regulate fundamental cellular processes, including the cell cycle and transcription.
- Dysregulation of CDKs and their associated proteins is linked to numerous diseases.
- CDK activity is modulated by binding partners (Cyclins) and phosphorylation.
Purpose of the Study:
- To elucidate the predominant roles of CDKs in cellular functions.
- To identify key interacting proteins and structural characteristics of CDKs.
- To summarize current strategies for CDK inhibition.
Main Methods:
- Literature review of CDK functions, interactions, and structural data.
- Analysis of protein-protein interactions involving CDKs.
- Summary of existing CDK inhibition research.
Main Results:
- CDKs are central regulators of cell cycle and transcription.
- CDK activity depends on Cyclin binding and phosphorylation.
- CDK4/6 inhibitors are approved for advanced breast cancer.
- Extensive protein-protein interactions offer numerous therapeutic targeting opportunities.
Conclusions:
- CDKs play vital roles in cellular activities and disease pathogenesis.
- Targeting CDKs presents a significant therapeutic strategy beyond current applications.
- Further research into CDK-protein interactions can yield novel therapeutic interventions.
Related Concept Videos
02:34Inhibition of Cdk Activity
02:04Protein-protein Interfaces
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:39Positive Regulator Molecules
00:50Anaphase Promoting Complex
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...